As of November 6, 2026, Jyong Biotech Ltd. is a publicly traded company (Nasdaq: MENS). The largest holder reporting an active stake on Schedule 13D is Perfect Minds Co., Ltd, at 33.34%. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D, April 24, 2026).
Is this your company?
About to sign with, pay or invest in Jyong Biotech Ltd.? See the free Snapshot first.
Free to see. No signup.
Is Jyong Biotech Ltd. a real, registered company?
- Jyong Biotech Ltd. files with the SEC under CIK 1954488 (its SEC filings).
- Its shares are listed under the ticker MENS on Nasdaq (SEC company record).
- Incorporated in E9, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Jyong Biotech Ltd. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Perfect Minds Co., Ltd (filed 2026-04-24).
Who are Jyong Biotech Ltd.'s owners and officers?
Jyong Biotech Ltd.: industry Pharmaceutical Preparations (Schedule 13D, 2026-04-24).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D, 2026-04-24 | Perfect Minds Co., LTD | 33.34% |
Want the whole picture on Jyong Biotech Ltd.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Jyong Biotech Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Jyong Biotech Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Jyong Biotech Ltd. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 25,349,500 shares (33.3% of shares outstanding), held indirectly through Held through Perfect Minds Co., Ltd, a Seychelles company. (Form 3, 2026-04-08).
- , a director: 3,000 shares (0.00% of shares outstanding) (Form 3, 2026-04-01).
- , a director: 3,000 shares (0.00% of shares outstanding) (Form 3, 2026-04-01).
Shares outstanding: 76,027,667 as of 2025-12-31, from the company's latest SEC cover page.
How much has Jyong Biotech Ltd. raised?
Latest IPO step: Jyong Biotech Ltd. filed its final IPO prospectus, ticker MENS (424B4, 2025-06-18).
IPO filings: 424B4, 2025-06-18, F-1/A, 2025-03-11, F-1/A, 2025-02-06, F-1/A, 2024-12-19, F-1/A, 2024-11-21; ticker MENS on Nasdaq Global Market.
Keep reading
More on Jyong Biotech Ltd. and the records around it.
Jyong Biotech Ltd. elsewhere on the record
- 5%+ stake filings Apr 2026
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/jyong-biotech